Page last updated: 2024-11-02

pd 98059 and Nervous System Disorders

pd 98059 has been researched along with Nervous System Disorders in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milton, NG1

Other Studies

1 other study available for pd 98059 and Nervous System Disorders

ArticleYear
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
    Neuroscience letters, 2002, Oct-31, Volume: 332, Issue:2

    Topics: Amyloid beta-Peptides; Arachidonic Acids; Cannabinoids; Corticotropin-Releasing Hormone; Endocannabi

2002